Effects of visfatin/PBEF/NAMPT on feeding behavior and hypothalamic neuromodulators in the rat

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 2, 2012, Pages 295-302

  Brunetti, L ^a   Recinella, L ^a   Di Nisio, C ^a   Chiavaroli, A ^a   Leone, S ^a   Ferrante, C ^a   Orlando, G ^a   Vacca, Michele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Feeding; Hypothalamus; NAMPT; PBEF; Visfatin

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DOPAMINE; NEUROPEPTIDE Y; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NORADRENALIN; PROOPIOMELANOCORTIN; SEROTONIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMUS; MALE; NEUROMODULATION; NONHUMAN; RAT;

AGOUTI-RELATED PROTEIN; ANIMALS; ARCUATE NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; FEEDING BEHAVIOR; HYPOTHALAMUS; MALE; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PRO-OPIOMELANOCORTIN; RATS; RATS, WISTAR;

EID: 84865047520     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20:68-100. (Pubitemid 29092036)
2. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404:661-71. (Pubitemid 30205071)
3. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 2001; 25(S)5:S63-7.
4. Brunetti L, Di Nisio C, Orlando G, Ferrante C, Vacca M. The regulation of feeding: a cross talk between peripheral and central signalling. Int J Immunopathol Pharmacol 2005; 18:201-12. (Pubitemid 40825883)
5. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129-39.
6. Bulcão C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF. The new adipose tissue and adipocytokines. Curr Diabetes Rev 2006; 2:19-28.
7. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307:426-30. Retraction in: Fukuhara A, Matsuda M, Nishizawa M et al. Science 2007; 318:565. (Pubitemid 40139988)
8. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54:2911-6.
9. Varma V, Yao-Borengasser A, Rasouli N, et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 2007; 92:666-72.
10. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14:1431-7.
11. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002;32:3225-34. (Pubitemid 35414880)
12. Revollo JR, Körner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007; 6:363-75.
13. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91:295-9. (Pubitemid 43069152)
14. Ingelsson E, Larson MG, Fox CS, et al. Clinical correlates of circulating visfatin levels in a community-based sample. Diabetes Care 2007;30:1278-80. (Pubitemid 46684663)
15. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007; 56:451-8. (Pubitemid 46427838)
16. Pagano C, Pilon C, Olivieri M, et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006; 91:3165-70. (Pubitemid 44271773)
17. Cline MA, Nandar W, Prall BC, Bowden CN, Denbow DM. Central visfatin causes orexigenic effects in chicks. Behav Brain Res 2008; 186:293-7. (Pubitemid 350122761)
18. Park BS, Jin SH, Park JJ, Park JW, Namgoong IS, Kim YI, Lee BJ, Kim JG. Visfatin induces sickness responses in the brain. PLoS One 2011; 6:e15981.
19. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Ed. Academic Press. New York, 2007.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. (Pubitemid 34164012)
21. Hallschmid M, Randeva H, Tan BK, Kern W, Lehnert H. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 2009; 58:637-40.
22. McGlothlin JR, Gao L, Lavoie T, Simon BA, Easley RB, Ma SF, Rumala BB, Garcia JG, Ye SQ. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 2005; 43:127-41. (Pubitemid 40543710)
23. Yang H, Yang T, Baur JA, et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007; 130:1095-107. (Pubitemid 47410271)
24. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002;143:185-90. (Pubitemid 34056418)
25. Sun G, Bishop J, Khalili S, et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007; 85:399-404. (Pubitemid 46220940)
26. Robertson MD, Henderson RA, Vist GE, Rumsey RD. Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord 2004; 28:727-33. (Pubitemid 38746217)
27. Samanin R, Garattini S. Neurochemical mechanism of action of anorectic drugs. Pharmacol Toxicol 1993; 73:63-8. (Pubitemid 23278474)
28. Pearl SM, Antion MD, Stanwood GD, Jaumotte JD, Kapatos G, Zigmond MJ. Effects of NADH on dopamine release in rat striatum. Synapse 2000;36:95-101. (Pubitemid 30196685)
29. Kristensen P, Judge ME, Thim L, et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998; 393:72-6. (Pubitemid 28240256)
30. Larsen PJ, Vrang N, Petersen PC, Kristensen P. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes Res 2000; 8:590-6.
31. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 1998; 29:293-8. (Pubitemid 28328673)
32. Stanley SA, Small CJ, Murphy KG, et al. Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 2001; 893:186-94. (Pubitemid 32171910)
33. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999; 23:775-86. (Pubitemid 29411566)
34. Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 1998; 47:890-3. (Pubitemid 28255661)
35. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98:1101-6. (Pubitemid 26299921)